We are live on
!
Find out more
SSWM
Smith Salley Wealth Management Portfolio holdings
AUM
$2.3B
1-Year Est. Return
38.65%
This Fund
S&P 500
This Quarter
Est. Return
+8.33%
1 Year Est. Return
+38.65%
3 Year Est. Return
+105.94%
5 Year Est. Return
+133.49%
10 Year Est. Return
+416.1%
AUM
$1.36B
AUM Growth
+$98.4M
(+7.8%)
Cap. Flow
+$9.71M
Cap. Flow
% of AUM
0.72%
Top 10 Holdings %
Top 10 Hldgs %
31.35%
Holding
237
New
11
Increased
113
Reduced
81
Closed
11
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Northrop Grumman
NOC
|
+$11.8M |
| 2 |
Elevance Health
ELV
|
+$10.8M |
| 3 |
Intel
INTC
|
+$3.99M |
| 4 |
Lowe's Companies
LOW
|
+$2.66M |
| 5 |
Bank of America
BAC
|
+$2.62M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Labcorp
LH
|
+$12.8M |
| 2 |
Walt Disney
DIS
|
+$10.5M |
| 3 |
Truist Financial
TFC
|
+$2.82M |
| 4 |
US Bancorp
USB
|
+$2.54M |
| 5 |
Crown Castle
CCI
|
+$1.97M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.75% |
| 2 | Financials | 15.76% |
| 3 | Healthcare | 11.36% |
| 4 | Industrials | 8.79% |
| 5 | Consumer Discretionary | 8.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NEXI
226
DELISTED
NexImmune, Inc. Common Stock
NEXI
| $2.82K | ﹤0.01% |
400
| – | – |
|
227
Amcor
AMCR
$22.1B
| – | – |
-33,641
| Closed | -$1.91M |
|
|
228
Crown Castle
CCI
$32.3B
| – | – |
-14,744
| Closed | -$1.97M |
|
229
Darden Restaurants
DRI
$23.8B
| – | – |
-1,293
| Closed | -$201K |
|
230
Elanco Animal Health
ELAN
$13.1B
| – | – |
-29,374
| Closed | -$276K |
|
231
iShares Ultra Short Duration Bond Active ETF
ICSH
$8.12B
| – | – |
-9,984
| Closed | -$502K |
|
232
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$23B
| – | – |
-4,027
| Closed | -$204K |
|
233
Illumina
ILMN
$30.2B
| – | – |
-1,185
| Closed | -$268K |
|
234
JPMorgan Ultra-Short Income ETF
JPST
$40.3B
| – | – |
-18,783
| Closed | -$945K |
|
235
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$33B
| – | – |
-3,965
| Closed | -$435K |
|
|
236
US Bancorp
USB
$100B
| – | – |
-70,374
| Closed | -$2.54M |
|
237
Vodafone
VOD
$35.4B
| – | – |
-16,756
| Closed | -$185K |
|
Similar funds
LFM
MAP
NSAM
LCM
GCP
ABI
LCM
CM
Smith Salley Wealth Management's Q2 2023 Portfolio in Review
As of Q2 2023, Smith Salley Wealth Management held 237 positions worth $1.36B, up 7.8% from $1.26B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Smith Salley Wealth Management's Q2 2023 filing shows 11 new, 113 increased, 81 reduced and 11 closed positions. Its largest new stake was Northrop Grumman: 26,007 shares worth $11.9M. The largest sale was Labcorp, an estimated $12.8M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Financials and Healthcare.
- Smith Salley Wealth Management's largest Q2 2023 buy was Northrop Grumman: 26,007 shares worth $11.9M.
- Smith Salley Wealth Management added most to Intel in Q2 2023, an estimated $3.99M increase.
- Smith Salley Wealth Management's biggest Q2 2023 reduction was Labcorp, cutting an estimated $12.8M.
- Smith Salley Wealth Management fully exited US Bancorp in Q2 2023, selling an estimated $2.54M.
- Smith Salley Wealth Management's ten largest holdings make up 31% of its $1.36B portfolio in Q2 2023.
- Smith Salley Wealth Management opened 11 new positions and closed 11 in Q2 2023.
- Smith Salley Wealth Management's portfolio value rose 7.8% quarter-over-quarter to $1.36B.
Based on Smith Salley Wealth Management's 13F filing for Q2 2023, filed 4 Aug 2023.